YK-11 is notable for its gene-selective partial agonism at the androgen receptor (AR) together with reported modulation of follistatin (FST)-associated transcriptional pathways. This combination of receptor-mediated signaling and follistatin-associated gene regulation differentiates YK-11 from many other androgen receptor modulators and has made it a valuable research tool for investigating AR-dependent transcriptional mechanisms, regulatory signaling networks, and pathway-specific gene expression processes.

YK-11 is classified as a steroidal androgen receptor modulator and is structurally derived from the androstane scaffold. This steroidal framework distinguishes it from non-steroidal androgen receptor modulators that utilize alternative chemical architectures.

The structural differences between steroidal and non-steroidal compounds make YK-11 useful for structure-activity relationship investigations examining receptor binding characteristics, co-regulator interactions, transcriptional responses, and androgen receptor pharmacology.

Follistatin (FST) is a regulatory glycoprotein involved in activin-associated signaling systems and transcriptional control processes. Experimental investigations involving YK-11 have examined relationships between androgen receptor activation, follistatin-associated regulatory pathways, and downstream gene expression mechanisms.

These characteristics have established YK-11 as a useful research tool for studies of AR-mediated signaling, transcriptional regulation, and the molecular interactions linking androgen receptor activity with follistatin-associated pathways.